Alerts will be sent to your verified email
Verify Email
AMERISE
|
Amerise Biosciences
|
Interface Financial
|
Amarnath Sec.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-0.33 % | -30.14 % | 2.69 % |
|
5yr average Equity Multiplier
|
1.37 | 3.34 | 1.18 |
|
5yr Average Asset Turnover Ratio
|
0.15 | 13.71 | 0.07 |
|
5yr Avg Net Profit Margin
|
1.22 % | -4.92 % | 30.99 % |
|
Price to Book
|
0.75 | 0.13 | 0.88 |
|
P/E
|
102.41 | 0.0 | 20.25 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | -71.12 Days | 0.0 |
|
Inventory Days
|
0.0 | 3.88 Days | 0.0 |
|
Days Receivable
|
0.0 | 3.08 Days | 0.0 |
|
Days Payable
|
27.62 Days | 20.83 Days | 0.0 |
|
5yr Average Interest Coverage Ratio
|
-378.51 | -207.72 | 409.0 |
|
5yr Avg ROCE
|
-0.34 % | -26.72 % | 4.32 % |
|
5yr Avg Operating Profit Margin
|
-0.04 % | -5.11 % | 49.27 % |
|
5 yr average Debt to Equity
|
0.01 | 0.06 | 0.14 |
|
5yr CAGR Net Profit
|
n/a | -14.37 % | n/a |
|
5yr Average Return on Assets
|
-1.23 % | -14.19 % | 2.23 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.0 | 0.0 | 0.0 |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -55.68 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Amerise Biosciences
|
Interface Financial
|
Amarnath Sec.
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|